Posted on

Kazakhstan Celebrates International Children’s Day With an Array of Spectacular Events Nationwide – The Astana Times

Kazakhstan Celebrates International Children’s Day With an Array of Spectacular Events Nationwide - The Astana Times

NUR-SULTAN – Kazakh President Kassym-Jomart Tokayev congratulated the country’s citizens on International Children’s Day which was celebrated on June 1, reports the presidential press service.

According to data released by the Kazakh Bureau of National statistics, approximately 6.5 million children under the age of 18 live in Kazakhstan. Photo credit: 24.kz

“International Children’s Day is a lovely holiday filled with special joy and warmth. This day reminds us once again that nothing is more important than the happiness and smiles of children,” said Tokayev.

The head of the state highlighted that many valuable projects and activities are being carried out to unleash the potential of each child as part of the Year of Children in 2022, which he declared in his New Year congratulatory address.

Joining the president’s congratulations, Kazakh Prime Minister Alikhan Smailov said at the June 1 government meeting that the most important task of the state is to create comfortable conditions for children in terms of learning, comprehensive development, recreation and medical care.

According to Smailov, providing safety for children in the street, near water and at various excursions remains the main task. He instructed officials to strengthen the work of the relevant services and provide the majority of children from socially vulnerable groups with more opportunities for rehabilitation, summer vacation and employment.

The country’s plan of activities for the Year of Children includes 66 events in seven areas aimed at ensuring safety, health, education, and recreation. 

One of these events was the Almaty BalaFest Kids’ festival, which Tokayev attended on June 1 during his working visit to Almaty from May 31 to June 1. He  congratulated the winners of the festival, which gathered approximately 300,000 participants to compete in literature, fine art, sports, arts and crafts, eco-competition, singing, dancing, and the IT sphere.

Tokayev during meeting with Almaty BalaFest Kids’ festival’s winners on June 1. Photo credit: Akorda Press

On the same day, the 17th Zhuldyzai charitable inclusive festival was held in Turkistan. This is the country’s only creative contest for children with physical and mental challenges to date.

“Since 2005, our festival has gathered more than 300 talented participants from 10 to 18 years old, and this number is growing every year. The selection is carried out at regional and national levels in four categories: singing, dancing, instrumental performance and sign singing,” said Zhuldyzai Public Fund Director Gulkhan Issabayeva in an interview with Zakon.kz news agency.

Some participants of Zhuldyzai festival in Turkistan. Photo credit: Zhuldyzai Public Fund

Overall, numerous festivities dedicated to the holiday were held nationwide, while nearly 60 events, including concerts, sports competitions, contests and entertaining games, took place in the Kazakh capital on June 1.

 

Posted on

Indivior Statement on Nationwide Increases in Fentanyl-Related Mass-Overdose Events

Indivior Statement on Nationwide Increases in Fentanyl-Related Mass-Overdose Events

Expanding access to medication to treat opioid use disorder is a critical part of the solution

RICHMOND, Va., April 12, 2022 /PRNewswire/ — Indivior PLC (LON: INDV) today released the following statement regarding the US Drug Enforcement Administration’s (DEA) recent memorandum to law enforcement partners offering guidance and support in response to a nationwide spike in fentanyl-related mass-overdose events.

Indivior (PRNewsfoto/Indivior)

“The DEA’s recent action reinforces the growing and unprecedented crisis of fentanyl-related overdose in the United States and provides guidance to help communities in their treatment and prevention efforts,” said Mark Crossley, Chief Executive Officer, Indivior. “A critical part of the solution is increased access to evidence-based medication for people struggling with the chronic disease of opioid and substance use disorder.”

The nation’s overdose epidemic is now driven by fentanyl.1 The CDC estimates that in the 12-month period ending in October 2021, more than 105,000 Americans died of drug overdoses, with 66 percent of those deaths related to synthetic opioids like fentanyl.1 These overdose deaths are affecting families and communities across the country, and the need for access to medications to treat opioid use disorder (MOUD) to help those suffering from opioid use disorder (OUD) and substance abuse has never been more critical.

To turn the tide on this devastating epidemic, Indivior is committed to expanding access to medications for opioid use disorder. One of the most critical needs is in under-served communities where racial and ethnic minorities face barriers to treatment access due to stigma or bias, heightening the inequities already present within our healthcare system. In addition, for those involved with the criminal justice system, approximately 65 percent1 meet the criteria for substance use disorder (SUD), yet only 5 percent2 of those who need treatment receive it.

About Opioid Use Disorder (OUD)

Opioid Use Disorder (OUD) is a chronic disease in which people develop a pattern of using opioids that can lead to negative consequences. OUD may affect the parts of the brain that are necessary for life-sustaining functions.3

About Indivior

Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorders (SUD) and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of SUD. Indivior is dedicated to transforming SUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 900 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.

References:

  1. National Institute on Drug Abuse: Criminal Justice Drug Facts. June 2020

    https://nida.nih.gov/publications/drugfacts/criminal-justice
  2. National Institute on Drug Abuse: Criminal Justice Drug Facts. June 2020

    https://www.drugabuse.gov/publications/drugfacts/criminal-justice
  3. U.S. Department of Health and Human Services (HHS), National Institute on Drug Abuse, National Institutes of Health. Drugs, Brains, and Behavior: The Science of Addiction. HHS Publication No. (SMA) 18-5063PT5, Printed 2018.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/indivior-statement-on-nationwide-increases-in-fentanyl-related-mass-overdose-events-301523621.html

SOURCE Indivior